Literature DB >> 15081269

Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells.

Andrés Jiménez1, Elvira G Jordà, Ester Verdaguer, David Pubill, Francesc X Sureda, Anna M Canudas, Elena Escubedo, Jordi Camarasa, Antoni Camins, Mercè Pallàs.   

Abstract

The neurotoxic action of the abuse drugs methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA) on cerebellar granule neurones (CGNs) culture was examined. Treatment for 48 h with METH or MDMA (1-5 mM) induced a higher decrease in viability than 24 h treatment. z.VAD.fmk (100 microM) but not MK-801 nor NBQX recovered control viability values. In both cases, cell death was characterised as apoptotic rather than necrotic by morphology cell observation. Apoptosis measured by flow cytometry indicated an increase in the hypodiploid population after 48 h treatment with METH and MDMA. Apoptosis was reverted by the presence of z.VAD.fmk (100 microM) but not by 10 microM MK-801 or NBQX. Similar results were obtained by analysing nuclear chromatine condensation. These results ruled out excitotoxic participation in amphetamine derivative-induced neurotoxicity in CGNs. Participation of radical oxygen species (ROS) was evaluated using alpha-tocopherol (1-15 microM) and cytometric studies. The co-treatment with 4 mM METH or MDMA for 48 h partially reverted neurotoxic action and apoptotic features, indicating ROS implication in CGNs death by amphetamine derivatives. Alteration of mitochondrial function induced cytochrome C (Cyt C) release after 48-h treatment with METH and MDMA (4 mM). There was also indication of caspase-3-like activation, measured by immunoanalysis and biochemically. Finally, neurodegenerative action caused by amphetamine derivatives may be prevented by using caspase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081269     DOI: 10.1016/j.taap.2003.12.017

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  25 in total

1.  Leber's hereditary optic neuropathy associated with cocaine, ecstasy and telithromycin consumption.

Authors:  Elena Cardaioli; Paola Da Pozzo; Gian Nicola Gallus; Rossella Franceschini; Alessandra Rufa; Maria Teresa Dotti; Aldo Caporossi; Antonio Federico
Journal:  J Neurol       Date:  2007-03-02       Impact factor: 4.849

2.  Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania.

Authors:  Gislaine T Rezin; Camila B Furlanetto; Giselli Scaini; Samira S Valvassori; Cinara L Gonçalves; Gabriela K Ferreira; Isabela C Jeremias; Wilson R Resende; Mariane R Cardoso; Roger B Varela; João Quevedo; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2013-10-15       Impact factor: 5.590

3.  Dopaminergic Neuron-Specific Deletion of p53 Gene Attenuates Methamphetamine Neurotoxicity.

Authors:  Tao Lu; Paul P Kim; Nigel H Greig; Yu Luo
Journal:  Neurotox Res       Date:  2017-03-24       Impact factor: 3.911

Review 4.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

5.  Neurotoxic effects of methamphetamine on rat hippocampus pyramidal neurons.

Authors:  N Hori; M T Kadota; M Watanabe; Y Ito; N Akaike; D O Carpenter
Journal:  Cell Mol Neurobiol       Date:  2010-03-16       Impact factor: 5.046

6.  Attenuation of ecstasy-induced neurotoxicity by N-acetylcysteine.

Authors:  Sara Soleimani Asl; Bita Saifi; Abolhasan Sakhaie; Somayeh Zargooshnia; Mehdi Mehdizadeh
Journal:  Metab Brain Dis       Date:  2014-08-06       Impact factor: 3.584

7.  Ecstasy (3,4-methylenedioxymethamphetamine) limits murine gammaherpesvirus-68 induced monokine expression.

Authors:  Daniel A Nelson; Jamie L Nirmaier; Sam J Singh; Melanie D Tolbert; Kenneth L Bost
Journal:  Brain Behav Immun       Date:  2008-02-15       Impact factor: 7.217

8.  The role of adenosine receptor agonist and antagonist on Hippocampal MDMA detrimental effects; a structural and behavioral study.

Authors:  Fatemeh Kermanian; Mehdi Mehdizadeh; Mansureh Soleimani; Ali Reza Ebrahimzadeh Bideskan; Majid Asadi-Shekaari; Hamed Kheradmand; Hossein Haghir
Journal:  Metab Brain Dis       Date:  2012-09-09       Impact factor: 3.584

Review 9.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

Review 10.  Methamphetamine toxicity and messengers of death.

Authors:  Irina N Krasnova; Jean Lud Cadet
Journal:  Brain Res Rev       Date:  2009-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.